For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

| Title | Content Type | Date | Description |
|---|---|---|---|
| Alendronate and its combinations: PBS listing extended to corticosteroid-induced osteoporosis | Professional publication - NPS RADAR - Brief item | 2010-11-09 00:00:00 | Alendronate and its combinations with calcium and/or cholecalciferol may be prescribed on the PBS for treating people who are currently receiving long-term high-dose corticosteroid therapy and have low bone mineral density. |
| Alendronate with cholecalciferol (vitamin D3) (Fosamax Plus) for osteoporosis | Professional publication - NPS RADAR - Review | 2008-12-01 00:00:00 | This new formulation of alendronate with cholecalciferol (vitamin D3) (Fosamax Plus) contains twice the cholecalciferol dose of the previous formulation — 5600 units in a once-weekly dose, equivalent to 800 units/day. The cholecalciferol 2800 unit formulation is gradually being phased out by the manufacturer. |
| Alendronate (Alendro Once Weekly, Fosamax Once Weekly, Fosamax Plus) for osteoporosis in people at high risk of fracture | Professional publication - NPS RADAR - Review | 2007-02-01 00:00:00 | Reviews extension of PBS listing for alendronate to include treatment of osteoporosis without fracture in older people with low bone mineral density scores. |

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.
Date published: 2009-10-30 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.